BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/14/2025 10:33:53 AM | Browse: 42 | Download: 161
 |
Received |
|
2024-10-04 07:12 |
 |
Peer-Review Started |
|
2024-10-04 07:12 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2024-11-10 08:16 |
 |
Revised |
|
2024-11-21 07:44 |
 |
Second Decision |
|
2025-01-08 02:37 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2025-01-08 07:55 |
 |
Articles in Press |
|
2025-01-08 07:55 |
 |
Publication Fee Transferred |
|
2024-12-16 03:49 |
 |
Edit the Manuscript by Language Editor |
|
2025-01-14 02:29 |
 |
Typeset the Manuscript |
|
2025-01-21 02:45 |
 |
Publish the Manuscript Online |
|
2025-02-14 10:33 |
ISSN |
1948-5204 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Immunology |
Manuscript Type |
Basic Study |
Article Title |
Irreversible electroporation combined with anti-programmed cell death protein 1 therapy promotes tumor antigen-specific CD8+ T cells response
|
Manuscript Source |
Unsolicited Manuscript |
All Author List |
Yang-Yang Ma, Xiao-Hua Wang, Jian-Ying Zeng, Ji-Bing Chen and Li-Zhi Niu |
ORCID |
|
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
Science and Technology Program of Guangzhou |
202102010077 |
International Science Foundation of Guangzhou Fuda Cancer Hospital |
Y2020-ZD-03 |
|
Corresponding Author |
Li-Zhi Niu, Chief Physician, MD, PhD, Department of Oncology, Guangzhou Fuda Cancer Hospital, No. 2 Tangde West Road, Tianhe District, Guangzhou 510665, Guangdong Province, China. niuboshi@fudahospital.com |
Key Words |
Irreversible electroporation; Pancreatic cancer; Programmed cell death protein 1 blockade; CD8+ T cell; Anticancer immunity |
Core Tip |
This study highlights the synergistic effect of combining irreversible electroporation with anti-programmed cell death protein 1 therapy in the treatment of subcutaneous pancreatic cancer. The combination significantly enhances T lymphocyte infiltration, elevates key cytokine levels, and promotes CD8+ T cell-mediated immune responses, resulting in a marked reduction in tumor volume. These findings suggest a promising avenue for improving immunotherapy strategies in pancreatic cancer through enhanced local tumor ablation methods. |
Publish Date |
2025-02-14 10:33 |
Citation |
<p>Ma YY, Wang XH, Zeng JY, Chen JB, Niu LZ. Irreversible electroporation combined with anti-programmed cell death protein 1 therapy promotes tumor antigen-specific CD8+ T cells response. <i>World J Gastrointest Oncol</i> 2025; 17(3): 101991</p> |
URL |
https://www.wjgnet.com/1948-5204/full/v17/i3/101991.htm |
DOI |
https://dx.doi.org/10.4251/wjgo.v17.i3.101991 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345